Skip to content

Conjugated Linoleic Acid in Obese Women

Effect of Conjugated Linoleic Acid Associated With Aerobic Exercise on Body Fat and Lipid Profile in Obese Women: A Randomized, Double-blinded and Placebo-controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02529046
Acronym
CLA
Enrollment
28
Registered
2015-08-19
Start date
2007-03-31
Completion date
2007-07-31
Last updated
2015-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid Metabolism Disorders, Obesity

Brief summary

In this trial, the investigators analyzed the effects of eight weeks of CLA supplementation associated with aerobic exercise on body fat and lipid profile in obese women.

Detailed description

The aim of this investigation was to analyze the effects of eight weeks of CLA supplementation associated with aerobic exercise on body fat and lipid profile in obese women. The investigators performed a randomized, double-blinded and placebo-controlled trial with 28 obese women who received 3.2 g/d of CLA or 4 g/d of olive oil (placebo group) while performing an 8-week protocol of aerobic exercise. Dietary intake (food record), body fat (DXA) and biochemical analysis (blood sample) were assessed before and after the intervention period.

Interventions

DIETARY_SUPPLEMENTCLA

CLA group received supplementation at a dose of 3.2 g/day (mixture of isomers of CLA isomers predominantly c9, t11 - 50% and c12, t10 - 80%). Aerobic exercise associated with CLA

BEHAVIORALPlacebo

Placebo group received 4 g/day of olive oil. Aerobic exercise

Sponsors

Universidade Estadual de Londrina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Had no signs or symptoms of disease * No orthopedic injuries * Must be inactive or moderately active (defined as performing any type of physical exercise less than twice a week) * Must be non-smokers * Must be free from the use of ergogenic aids * Had no metabolic disorders or chronic degenerative diseases * Not use drug therapy for body mass loss.

Exclusion criteria

* Had frequency to training sessions below 85% of the total sessions

Design outcomes

Primary

MeasureTime frameDescription
Body fat8 weeksDual-energy X-ray absorptiometry

Secondary

MeasureTime frameDescription
Total cholesterol8 weeksBlood analysis
Triglycerides8 weeksBlood analysis
High-density lipoprotein8 weeksBlood analysis
Low-density lipoprotein8 weeksEstimated by Friedewald formula
Arm fat8 weeksDual-energy X-ray absorptiometry
Leg fat8 weeksDual-energy X-ray absorptiometry
Trunk fat8 weeksDual-energy X-ray absorptiometry

Other

MeasureTime frameDescription
Body mass8 weeksUrano, model PS 180
Maximum oxygen uptake8 weeksincremental treadmill test

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026